CARCINOMA IN SITU OF PENIS

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting CARCINOMA IN SITU OF PENIS:

# Drug Count
0 INFLIXIMAB 3
1 VEDOLIZUMAB 3
2 RAMIPRIL 2
3 RITUXIMAB 2
4 AMLODIPINE 1
5 ASPIRIN 1
6 ASPIRIN 325 MG 1
7 ASPIRIN 81 MG 1
8 CYCLOPHOSPHAMIDE 1
9 CYCLOPHOSPHAMIDE FOR INJECTION 1
See all common drugs associated with CARCINOMA IN SITU OF PENIS

CARCINOMA IN SITU OF PENIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IMIQUIMOD 1 0.0004
1 VEDOLIZUMAB 3 0.0000
2 ENALAPRIL 1 0.0000
3 RAMIPRIL 2 0.0000
4 INFLIXIMAB 3 0.0000
5 HYDROXYCHLOROQUINE SULFATE 1 0.0000
6 USTEKINUMAB 1 0.0000
7 RITUXIMAB 2 0.0000
8 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
9 CYCLOPHOSPHAMIDE 1 0.0000
See all drugs enriched for association with CARCINOMA IN SITU OF PENIS